Meeting
2021 ASCO Annual Meeting
Clinico-pathological and genomic features of NRAS- or HRAS-mutated non-small cell lung cancer (NSCLC) identified in large-scale genomic screening project (LC-SCRUM-Asia).
Authors
Yutaro Tamiya
National Cancer Center Hospital East, Kashiwa, Japan
Yutaro Tamiya , Shingo Matsumoto , Takaya Ikeda , Kiyotaka Yoh , Terufumi Kato , Kazumi Nishino , Masahiro Kodani , Atsushi Nakamura , Naoki Furuya , Shoichi Kuyama , Shingo Miyamoto , Ryo Toyozawa , Masato Shingyoji , Tomoyuki Naito , Satoshi Oizumi , Hiroshi Tanaka , Hibiki Udagawa , Kaname Nosaki , Yoshitaka Zenke , Koichi Goto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9054)
DOI
10.1200/JCO.2021.39.15_suppl.9054
Abstract #
9054
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS–mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).
First Author: Yutaro Tamiya
Poster
2022 ASCO Annual Meeting
Impact of RAS mutations on immunologic characteristics of the tumor microenvironment (TME) in patients with microsatellite instability-high (MSI-H) or mismatch-repair–deficient (dMMR) colorectal cancer (CRC).
First Author: Mohamed E. Salem
Poster
2018 ASCO Annual Meeting
Early prediction of outcomes to PD1 inhibitors in non-small cell lung cancer (NSCLC) using next generation sequencing (NGS) of plasma circulating tumor DNA (ctDNA).
First Author: Nicolas Guibert
Poster
2014 ASCO Annual Meeting
PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
First Author: Sascha Ansen